Clinical Observation On Moxibustion Combined With Bloodletting Therapy For Liver And Kidney Deficiency Cervical Spondylotic Radiculopathy

Objective:The purpose of this project is to observe the clinical efficacy of moxibustion combined with bloodletting therapy in the treatment of liver and kidney deficiency cervical spondylotic radiculopathy,To explore a safe and effective,simple and easy-to-use,green and healthy therapy for the treatment of liver and kidney deficiency cervical spondylotic radiculopathy.Methods:72 patients with liver and kidney deficiency cervical spondylotic radiculopathy were divided into treatment group(36 cases)and control group(36 cases)by random array table method.The treatment group was treated with moxibustion and bloodletting therapy,The control group received oral Diclofenac Sodium Sustained Release Tablets and Mecobalamin Tablets,The treatment period in both groups was 4 weeks.Compare the two groups before and after treatment with VAS score,Tanaka Yasuhisa 20-point scale,NPQ score,and overall efficacy after treatment.and the VAS and NPQ scores were followed up by telephone one month after the end of treatment.Results:1.The VAS score:Intra-group comparison,compared with before and after treatment,the differences were statistically significant(P<0.05);Compared with follow-up and post-treatment,There was no significant difference in the treatment group(P>0.05),There was significant difference in the control group(P<0.05).Comparison between two groups,there was no statistically significant difference before treatment(P>0.05),after treatment and follow-up,there was statistically significant difference before treatment(P<0.05).2.Tanaka Yasuhisa 20-point scale for cervical spondylosis symptoms:Intra-group comparison,compared with before and after treatment,the differences were statistically significant(P<0.05).Comparison between two groups,there was no statistically significant difference before treatment(P>0.05),there was statistically significant difference after treatment(P<0.05).3.The NPQ score:Intra-group comparison,compared with before and after treatment,the differences were statistically significant(P<0.05);Compared with follow-up and post-treatment,There was no significant difference in the treatment group(P>0.05),There was significant difference in the control group(P<0.05).Comparison between two groups,there was no statistically significant difference before treatment(P>0.05),after treatment and follow-up,there was statistically significant difference before treatment(P<0.05).4.Efficacy Evaluation:There is statistically significant difference between the two groups(P<0.05),the average rank of the treatment group was lower than that of the control group,indicating that the overall efficacy of the treatment group was better than that of the control group.Conclusions:1.Moxibustion combined with bloodletting therapy and western medicine are effective in treating liver and kidney deficiency CSR,The overall effect of moxibustion combined with bloodletting is superior to western medicine.2.Moxibustion combined with bloodletting therapy for liver and kidney deficiency CSR can have a good analgesic effect,can better improve the clinical symptoms and signs of patients,and improve quality of life,and it can play a better role in maintaining the effect after the treatment.